Advances in Three-Dimensional Cell Culture in Drug Research and Discovery
Presented At:
LabRoots - Drug Discovery Virtual Event 2019
Presented By:
Richard Eglen, PhD - Vice President and General Manager, Corning Life Sciences
Speaker Biography:
Dr. Richard M. Eglen is Vice President and General Manager of Corning Life Sciences. Dr. Eglen has over 40 years' experience in the Life Sciences industry. Prior to joining Corning in 2011, he was president of Bio-discovery at PerkinElmer and held other executive management positions in the pharmaceutical, diagnostic, and biotech industries. Dr. Eglen has extensive experience in the use of cellular biology to study key drug targets, including GPCRs, kinases, and ion channels. He has also wide experience in assay and instrument technology development for high-throughput screening, imaging, and biomarker detection. He has authored over 350 publications, book chapters, and patents, and serves on numerous industry, academic advisory, and journal editorial boards.
Webinar:
Advances in Three-Dimensional Cell Culture in Drug Research and Discovery
Webinar Abstract:
Cellular research is optimal when using physiologically-relevant cell phenotypes and genotypes of human origin. This assertion has accelerated the adoption of primary cells, stem cells, and increasingly, patient-specific cells in drug discovery. Over the last five years, technological improvements in three-dimensional (3D) cell culture technology, to better mimic in vivo physiology, have also accelerated, not only in the areas of cancer and neurological research, but also in the assessment of clinical candidates for metabolic and toxicological liabilities. In this presentation, existing, and future, developments in 3D cell culture technology, (including the use of phenotypically-relevant human iPS cells) on fundamental research and drug discovery will be addressed.
Learning Objectives:
1. Understanding current status of 3D technologies
2. Understanding applications to disease modeling and drug discovery
Earn PACE/CME Credits:
1. Make sure you’re a registered member of LabRoots (https://www.labroots.com/virtual-event/drug-discovery-2019)
2. Watch the webinar on YouTube above or on the LabRoots Website (https://www.labroots.com/virtual-event/drug-discovery-2019)
3. Click Here to get your PACE (Expiration date – February 27, 2021 12:00 PM) – https://www.labroots.com/credit/pace-credits/3328/third-party
LabRoots on Social:
Facebook: https://www.facebook.com/LabRootsInc
Twitter: https://twitter.com/LabRoots
LinkedIn: https://www.linkedin.com/company/labroots
Instagram: https://www.instagram.com/labrootsinc
Pinterest: https://www.pinterest.com/labroots/
SnapChat: labroots_inc
Видео Advances in Three-Dimensional Cell Culture in Drug Research and Discovery канала LabRoots
LabRoots - Drug Discovery Virtual Event 2019
Presented By:
Richard Eglen, PhD - Vice President and General Manager, Corning Life Sciences
Speaker Biography:
Dr. Richard M. Eglen is Vice President and General Manager of Corning Life Sciences. Dr. Eglen has over 40 years' experience in the Life Sciences industry. Prior to joining Corning in 2011, he was president of Bio-discovery at PerkinElmer and held other executive management positions in the pharmaceutical, diagnostic, and biotech industries. Dr. Eglen has extensive experience in the use of cellular biology to study key drug targets, including GPCRs, kinases, and ion channels. He has also wide experience in assay and instrument technology development for high-throughput screening, imaging, and biomarker detection. He has authored over 350 publications, book chapters, and patents, and serves on numerous industry, academic advisory, and journal editorial boards.
Webinar:
Advances in Three-Dimensional Cell Culture in Drug Research and Discovery
Webinar Abstract:
Cellular research is optimal when using physiologically-relevant cell phenotypes and genotypes of human origin. This assertion has accelerated the adoption of primary cells, stem cells, and increasingly, patient-specific cells in drug discovery. Over the last five years, technological improvements in three-dimensional (3D) cell culture technology, to better mimic in vivo physiology, have also accelerated, not only in the areas of cancer and neurological research, but also in the assessment of clinical candidates for metabolic and toxicological liabilities. In this presentation, existing, and future, developments in 3D cell culture technology, (including the use of phenotypically-relevant human iPS cells) on fundamental research and drug discovery will be addressed.
Learning Objectives:
1. Understanding current status of 3D technologies
2. Understanding applications to disease modeling and drug discovery
Earn PACE/CME Credits:
1. Make sure you’re a registered member of LabRoots (https://www.labroots.com/virtual-event/drug-discovery-2019)
2. Watch the webinar on YouTube above or on the LabRoots Website (https://www.labroots.com/virtual-event/drug-discovery-2019)
3. Click Here to get your PACE (Expiration date – February 27, 2021 12:00 PM) – https://www.labroots.com/credit/pace-credits/3328/third-party
LabRoots on Social:
Facebook: https://www.facebook.com/LabRootsInc
Twitter: https://twitter.com/LabRoots
LinkedIn: https://www.linkedin.com/company/labroots
Instagram: https://www.instagram.com/labrootsinc
Pinterest: https://www.pinterest.com/labroots/
SnapChat: labroots_inc
Видео Advances in Three-Dimensional Cell Culture in Drug Research and Discovery канала LabRoots
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
CANCER ON A CHIP: A microfluidic 2D and 3D cell culture system..Bringing Cell Culture into the 21st Century | Margaret Magdesian | TEDxMontrealNicholas Dolman - High content imaging and analysis for drug discovery phenotypic assays...Mammalian cell culture 2 - cell lines and cell strainCAR T-cell therapy: Reprogramming the immune system to treat cancer | Rob Weinkove | TEDxTauranga3D printing tissue and organs (Tissue engineering - 2019)Cell Culture (Attached Cell)Animal cell culture 7 - cell culture in mediaCAR T-cell TherapyGenomic Advances in Drug Discovery & Development - Lon Cardon, Ph.D.Drug discovery and development processNanotechnology in Cancer Research | Jessica Winter | TEDxColumbusMark Murcko lectures on drug discovery in pharmaceutical industryUsing Artificial Intelligence to revolutionise drug discovery and developmentCompanion Diagnostic and Biomarker Assay Development for Interrogation of Liquid and Solid TumorAnimal cell culture 9 - culture mediaMaximize your cell culture Technical tips for primary cells and cell analysesHow to Grow Cancer Cells as Free Floating Tumor Spheroids by Dr. Dipanjan BasuGrow Cancer Spheroid Cultures w/ Thermo Scientific Nunclon™ Sphera™ productsIntroduction into 3D cell culture with Alvetex Scaffold